Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
METHODS
Patient population. The cohort was derived from consecutive adults referred for symptom-limited treadmill testing
at the Cleveland Clinic Foundation between September
1990 and March 1998. All patients were undergoing their
first treadmill test at our institution. Patients were eligible if
they underwent coronary angiography within 90 days. Exclusion criteria included a history of heart failure, valvular
disease, pre-excitation, congenital disease, coronary interventions or surgery, pacemaker placement, use of digoxin,
atrial fibrillation, and absence of a recorded U.S. Social
Security number. The Cleveland Clinic Foundations Institutional Review Board approved the performance of research on this clinical data base.
Of the 2,935 patients who met these criteria, 1,384 (47%)
have been included in previous publications (1,4,5). However, we have not published any data on their angiographic
characteristics relation to HRR or whether HRR predicts
death in these patients once angiographic data are known.
Clinical data. A structured interview and chart review were
conducted before each treadmill test regarding symptoms,
medications, risk factors, cardiac history, and noncardiac
diagnoses (8). Resting hypertension was defined as systolic
blood pressure 140 mm Hg, diastolic blood pressure 90
mm Hg, or treatment with antihypertensive medication (9).
832
Vivekananthan et al.
Heart Rate Recovery and Coronary Disease
Vivekananthan et al.
Heart Rate Recovery and Coronary Disease
833
Characteristic
Normal HRR
(>12 beats/min)*
(n 2,097)
Abnormal HRR
(<12 beats/min)
(n 838)
p Value
Age (yrs)
Male gender
White race
Hypertension
Resting tachycardia (100 beats/min)
Current or recent smoker
Insulin use
NIDDM
Hypercholesterolemia
Previous CAD
Previous MI
ACE inhibitor use
Beta-blocker use
Aspirin use
Diuretic use
Nondihydropyridine calcium channel blocker use
Nitrates
Vasodilators
Peripheral vascular disease
COPD
Asthma
ESRD
59 10
1,594 (76%)
1,863 (89%)
926 (44%)
53 (3%)
407 (19%)
88 (4%)
183 (9%)
840 (40%)
1,000 (48%)
504 (24%)
244 (12%)
553 (26%)
832 (40%)
275 (13%)
193 (9%)
570 (27%)
838 (40%)
61 (3%)
56 (3%)
57 (3%)
14 (0.7%)
63 10
621 (74%)
732 (87%)
505 (60%)
72 (9%)
181 (22%)
72 (9%)
126 (15%)
317 (38%)
435 (52%)
246 (29%)
151 (18%)
271 (32%)
337 (40%)
172 (21%)
96 (11%)
278 (33%)
435 (57%)
35 (4%)
60 (8%)
23 (3%)
20 (2%)
0.0001
0.23
0.25
0.0001
0.0001
0.19
0.0001
0.0001
0.26
0.04
0.003
0.0001
0.001
0.79
0.0001
0.04
0.001
0.0001
0.08
0.0001
0.97
0.0001
*For stress echocardiography, 18 beats/min. For stress echocardiography, 18 beats/min. Data are presented as the mean
value SD or number (%) of subjects.
ACE angiotensin-converting enzyme; CAD coronary artery disease; COPD chronic obstructive pulmonary disease;
ESRD end-stage renal disease; HRR heart rate recovery; MI myocardial infarction; NIDDM noninsulin-dependent
diabetes mellitus.
RESULTS
Baseline, exercise, and angiographic characteristics. Of
2,935 eligible patients, 838 (29%) had abnormal HRR.
Baseline characteristics according to HRR are summarized
in Table 1. Patients with abnormal HRR were older, more
likely to have hypertension or diabetes, and more likely to
have a history of myocardial infarction.
Exercise and angiographic characteristics are presented in
Tables 2 and 3. Patients with abnormal HRR were more
likely to have chronotropic incompetence and less likely to
have abnormal ST-segment changes. Severe CAD was
present in 421 patients (14%). Patients with abnormal HRR
were more likely to have severe CAD (p 0.02). However,
abnormal HRR had a sensitivity of only 31% and a
specificity of 76% for the detection of any CAD.
834
Vivekananthan et al.
Heart Rate Recovery and Coronary Disease
Normal HRR
(n 2,097)
Abnormal HRR
(n 838)
p Value
8.5 2.3
6.5 1.7
247 (12%)
537 (26%)
146 22
489 (23%)
6.9 2.2
5.3 1.6
203 (24%)
289 (34%)
134 22
298 (36%)
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
23 8
476 (23%)
49 (2%)
578 (28%)
85
175 (21%)
18 (2%)
168 (20%)
0.0001
0.28
0.75
0.0001
Normal HRR
(n 2,097)
Abnormal HRR
(n 838)
p Value
19 (032)
1,279 (61%)
280 (13%)
79 (4%)
476 (23%)
593 (29%)
757 (36%)
537 (25%)
23 (037)
576 (69%)
141 (17%)
41 (5%)
230 (27%)
282 (34%)
368 (43%)
269 (32%)
0.0001
0.0001
0.02
0.16
0.007
0.004
0.0001
0.0004
Data are presented as the median value (interquartile range) or number (%) of subjects.
CAD coronary artery disease; HRR heart rate recovery; LAD left anterior descending; LCx left circumflex
coronary artery; LMCA left main coronary artery; PDA posterior descending artery; RCA right coronary artery.
Vivekananthan et al.
Heart Rate Recovery and Coronary Disease
835
HR
(95% CI)
Chi-Squared
Statistic
p Value
2.1 (1.72.6)
1.9 (1.52.4)
1.9 (1.52.3)
2.0 (1.62.6)
1.9 (1.52.4)
2.8 (2.13.7)
3.2 (2.05.2)
1.6 (1.22.1)
2.0 (1.43.1)
2.0 (1.62.6)
1.5 (1.02.3)
1.2 (0.91.5)
43
34
32
30
24
23
22
13
12
10
4
1
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0004
0.0005
0.0013
0.04
0.32
CI confidence interval; CRI chronotropic response index; EF ejection fraction; HR hazard ratio; other abbreviations
as in Table 1.
Figure 1. Kaplan-Meier plot relating heart rate (HR) recovery and angiographic severity of coronary artery disease (CAD) to risk of death.
836
Vivekananthan et al.
Heart Rate Recovery and Coronary Disease
Percentage of Bootstrap
Models Entered
Adjusted HR
(95% CI)
100
99
97
93
89
84
83
83
82
79
79
72
68
65
61
51
1.9 (1.72.2)
0.6 (0.50.7)
1.6 (1.22.0)
2.1 (1.52.9)
1.7 (1.32.2)
0.6 (0.40.8)
1.5 (1.12.0)
3.1 (1.56.2)
1.5 (1.21.9)
1.5 (1.12.0)
1.9 (1.12.8)
1.8 (1.12.6)
1.4 (1.11.9)
1.3 (1.01.7)
1.5 (1.02.2)
1.4 (1.01.9)
*See Methods section of text for details regarding bootstrap resampling methods and modeling techniques. Models in which
the variable was retained at p 0.05.
CI confidence interval; HR hazard ratio; other abbreviations as in Table 1.
DISCUSSION
Among patients who had exercise stress testing and who
had coronary angiography within 90 days, an attenuated
HRR after exercise predicted mortality. The mortality risk
of abnormal HRR was comparable to having angiographically severe CAD (15,16). In fact, abnormal HRR provided
additive prognostic information to the angiographic severity
of CAD.
Previously, our group found that abnormal HRR predicted mortality in multiple patient groups (15). Only one
previous study (6) has evaluated the prognostic significance
of abnormal HRR once the angiographic severity of CAD is
ascertained. In a male veteran population, Shetler et al. (6)
found abnormal HRR to be predictive of increased mortality, independent of the angiographic severity of CAD.
Attenuated HRR was not helpful in predicting the presence
of significant angiographic coronary disease.
Our study confirms and extends these findings in several
important respects. First, 25% of our patients were women,
among whom HRR predicted death, independent of coronary disease severity, to the same extent as in men. Second,
our study included patients who underwent either standard
exercise stress testing with a 2-min upright cool-down
period or stress echocardiography, which, per protocol, did
not have an upright cool-down period. Irrespective of the
testing protocol used, we found abnormal HRR to be
independently predictive of death, even after accounting for
the angiographic severity of coronary disease. Third, we also
confirmed that HRR is a poor diagnostic test for angiographic CAD, with a sensitivity of only 31% and a specificity of 76%. Finally, our use of bootstrap resamplings and
parametric analyses enabled us to deal with excessive overoptimism inherent when analyzing only one data set and to
explore the importance of HRR when considered as a
continuous variable.
Our study adds to growing evidence that abnormal HRR
adversely affects mortality, independent of ischemic burden
(1,5). The drop in heart rate after exercise is thought to
represent withdrawal of the sympathetic nervous system
and, more importantly, reactivation of the parasympathetic
nervous system (27,28). Reduced vagal activity has been
shown to adversely impact mortality in other patient populations (29,30).
At this time, additional study is needed to delineate
therapeutic options for patients with abnormal HRR and to
determine whether HRR is a modifiable risk factor. To
date, no therapy has been systematically investigated for its
ability to attenuate the risk associated with abnormal HRR.
Preliminary evidence does suggest that cardiac rehabilitation
improves HRR (31).
Our study was limited because it involved a single
tertiary-care referral center and thus was open to biases of
Vivekananthan et al.
Heart Rate Recovery and Coronary Disease
837
patient selection and referral patterns for coronary angiography. Moreover, the use of coronary angiography alone as
a risk factor for future cardiac events has been called into
question (32). Due to inherent problems of vessel overlap,
vessel tortuosity, and vessel resolution, stenoses can be overand/or underestimated. In addition, the degree of luminal
stenoses may not correlate with the propensity for plaque
rupture. Finally, our study did not identify specific causes of
death, but used all-cause mortality as the end point.
We found that HRR provides additive prognostic information to the angiographic severity of coronary disease. Our
findings provide further evidence supporting the routine
incorporation of HRR into exercise testing interpretation.
Reprint requests and correspondence: Dr. Michael S. Lauer,
Desk F25, Department of Cardiovascular Medicine, Cleveland
Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195.
E-mail: Lauerm@ccf.org.
REFERENCES
1. Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer MS.
Heart-rate recovery immediately after exercise as a predictor of
mortality. N Engl J Med 1999;341:13517.
2. Cole CR, Foody JM, Blackstone EH, Lauer MS. Heart rate recovery
after submaximal exercise testing as a predictor of mortality in a
cardiovascularly healthy cohort. Ann Intern Med 2000;132:5525.
3. Watanabe J, Thamilarasan M, Blackstone EH, Thomas JD, Lauer
MS. Heart rate recovery immediately after treadmill exercise and left
ventricular systolic dysfunction as predictors of mortality: the case of
stress echocardiography. Circulation 2001;104:19116.
4. Diaz LA, Brunken RC, Blackstone EH, Snader CE, Lauer MS.
Independent contribution of myocardial perfusion defects to exercise
capacity and heart rate recovery for prediction of all-cause mortality in
patients with known or suspected coronary heart disease. J Am Coll
Cardiol 2001;37:1558 64.
5. Nishime EO, Cole CR, Blackstone EH, Pashkow FJ, Lauer MS.
Heart rate recovery and treadmill exercise score as predictors of
mortality in patients referred for exercise ECG. JAMA 2000;284:
13928.
6. Shetler K, Marcus R, Froelicher VF, et al. Heart rate recovery:
validation and methodologic issues. J Am Coll Cardiol 2001;38:
1980 7.
7. Lauer MS, Blackstone EH, Young JB, Topol EJ. Cause of death in
clinical research: time for a reassessment? J Am Coll Cardiol 1999;34:
618 20.
8. Snader CE, Marwick TH, Pashkow FJ, Harvey SA, Thomas JD,
Lauer MS. Importance of estimated functional capacity as a predictor
of all-cause mortality among patients referred for exercise thallium
single-photon emission computed tomography: report of 3,400 patients from a single center. J Am Coll Cardiol 1997;30:6418.
9. The Fifth Report of the Joint National Committee on Detection,
Evaluation, and Treatment of High Blood Pressure (JNC-V). Arch
Intern Med 1993;153:154 83.
10. Lauer MS, Francis GS, Okin PM, Pashkow FJ, Snader CE, Marwick
TH. Impaired chronotropic response to exercise stress testing as a
predictor of mortality. JAMA 1999;281:524 9.
11. Lauer MS, Pashkow FJ, Snader CE, Harvey SA, Thomas JD,
Marwick TH. Gender and referral for coronary angiography after
treadmill thallium testing. Am J Cardiol 1996;78:278 83.
12. Lauer MS, Pashkow FJ, Harvey SA, Marwick TH, Thomas JD.
Angiographic and prognostic implications of an exaggerated exercise
systolic blood pressure response and rest systolic blood pressure in
adults undergoing evaluation for suspected coronary artery disease.
J Am Coll Cardiol 1995;26:1630 6.
13. Marwick TH, Mehta R, Arheart K, Lauer MS. Use of exercise
echocardiography for prognostic evaluation of patients with known or
suspected coronary artery disease. J Am Coll Cardiol 1997;30:8390.
838
Vivekananthan et al.
Heart Rate Recovery and Coronary Disease
14. Brener SJ, Pashkow FJ, Harvey SA, Marwick TH, Thomas JD, Lauer
MS. Chronotropic response to exercise predicts angiographic severity
in patients with suspected or stable coronary artery disease. Am J
Cardiol 1995;76:1228 32.
15. Jones RH, Kesler K, Phillips HR 3rd, et al. Long-term survival
benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. J Thorac
Cardiovasc Surg 1996;111:101325.
16. Mark DB, Nelson CL, Califf RM, et al. Continuing evolution of
therapy for coronary artery disease: initial results from the era of
coronary angioplasty. Circulation 1994;89:201525.
17. Curb JD, Ford CE, Pressel S, Palmer M, Babcock C, Hawkins CM.
Ascertainment of vital status through the National Death Index and
the Social Security Administration. Am J Epidemiol 1985;121:754
66.
18. Boyle CA, Decoufle P. National sources of vital status information:
extent of coverage and possible selectivity in reporting. Am J Epidemiol 1990;131:160 8.
19. Newman TB, Brown AN. Use of commercial record linkage software
and vital statistics to identify patient deaths. J Am Med Inform Assoc
1997;4:2337.
20. Cox S. Regression models and life tables. J Am Stat Soc 1972;34:187
220.
21. Cain KC, Lange NT. Approximate case influence for the proportional
hazards regression model with censored data. Biometrics 1984;40:
4939.
22. Chen CH, George SL. The bootstrap and identification of prognostic
factors via Coxs proportional hazards regression model. Stat Med
1985;4:39 46.
23. Collett D, Stepniewska K. Some practical issues in binary data
analysis. Stat Med 1999;18:2209 21.